Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

For 'Hands-Free' Body Contouring, BTL Vanquish ME is the Hands-Down Winner

BTL Aesthetics
Posted on: 01 Nov 16

PR Newswire

BOSTON, Nov. 1, 2016

BOSTON, Nov. 1, 2016 /PRNewswire/ -- BTL Aesthetics today announced the release of a peer review study, published in the Journal of Drugs in Dermatology (JDD), addressing effectiveness and patient satisfaction of three "hands-free" noninvasive body contouring devices: cryolipolysis, 1060nm diode laser, and BTL Vanquish ME. The study, written by Drs. Suneel Chilukuri and Gregory Meuller, analyzed peer reviewed studies on the three devices and their mechanism of action, as well as on their evidence of safety and efficacy.

Based on the facts presented, BTL Vanquish ME was proven to be more cost effective and to remove fat faster—three to five times more speed coverage, per treatment regimen—over a higher coverage area.

"We are excited to see this review published, as it shows that BTL Vanquish ME satisfies body sculpting patients' needs: Efficacy and speed in fat removal, but also cost efficiencies," said Tomas Boleslavsky, Director of Clinical at BTL Aesthetics. "This data, coupled with other research, actually allowed us to calculate the cost of fat removal per ounce—which, for BTL Vanquish ME, is $78/ounce compared to nearly $1K for our competitors." 

BTL Vanquish ME is a physician-favored treatment that is FDA-cleared for the circumferential reduction of the abdomen and thighs. The clearance was secured following several rounds of clinical testing to provide ample evidence of its efficacy and safety—which has also been previously documented thanks to articles published in peer-reviewed journals. BTL Vanquish ME is unique in the market, as it was also awarded a patent in September for the method in which the device uses feedback power control for non-invasive treatment of skin and human tissue. This patented method allows BTL Vanquish ME to deliver the optimum amount of entry to the patient, while reducing the thermal load of the patient and device.

Removal at 3-5 Times Faster Rate

Harnessing the power of high-frequency, Selective RF energy, BTL Vanquish ME induces death of fat cells through apoptosis, and the body flushes fat cells out of the body naturally to help slim the abs, belly, love handles, and now thighs. The JDD review showed that speed coverage (cm2/min), which is defined as the rate at which a device can treat a spot size, was 11.7 cm2/min for BTL Vanquish ME core applicator (for the abdomen) and 7.3 cm2/min for the flex applicator (for thighs). Those calculations are based on the recommended regimen protocol of four 45-minute treatments in consecutive weeks. Compared to speed coverage of the other devices in the study, 0.5-1.1 cm2/min for cryolipolysis and 3.8 cm2/min for 1060 diode laser), BTL Vanquish ME was three-five times faster.

Higher Fat Removal Coverage Area

Boasting the largest spot size in the industry, the unique contactless panel of BTL Vanquish ME allows patients to treat a broader area at once, resulting in more even results with no lines of demarcation. Based on the studies, BTL Vanquish core and flex applicators proved to have > up to 33 times more spot coverage than its competitors: 2100 cm2 (core applicator) and 1317 cm2 spot size (flex applicator); while the spot size for cryolipolysis and 1060 diode laser was 63 cm2 and 96 cm2, respectively.

Contactless Device = No Pain

Further, BTL Vanquish ME was shown to have extremely minimal side effects, such as tenderness, that resolved quickly. By contrast, the JDD article reported mean pain scores for the 1060 diode laser was 3.7 out of 10 for abdominal, and 4.0 out of 10 for flanks, as well as mild to moderate tenderness lasting up to two weeks after treatment. Cryolipolysis showed a multitude of reported side effects, ranging from erythema (100%) to clay-like skin (52%), to bruising (9.8%) and severe pain (4%). 

BTL Vanquish ME treatments are available through a network of licensed physicians and medically supervised spas. Visit www.btlvanquishme.com to find a physician for treatment.

About BTL Industries

Founded in 1993, BTL Industries is a privately owned developer and manufacturer of medical and aesthetic equipment. BTL currently has over 1,200 employees and direct offices in more than 53 countries. BTL Aesthetics, a division of BTL Industries, has revolutionized the way to non-invasively remove adipose tissue; it currently ranks among the largest non-invasive body shaping and tightening manufacturers globally. BTL Aesthetics' brands include BTL Vanquish ME, BTL Exilis Ultra, and BTL Cellutone.

Additional information can be found at http://www.btlaesthetics.com.  

Logo - http://photos.prnewswire.com/prnh/20160425/359513LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/for-hands-free-body-contouring-btl-vanquish-me-is-the-hands-down-winner-300355101.html

SOURCE BTL Aesthetics

PR Newswire
www.prnewswire.com

Last updated on: 01/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.